IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 214 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $718,000 | -68.4% | 55,000 | -68.8% | 0.01% | -73.3% |
Q2 2021 | $2,272,000 | -8.4% | 176,548 | -20.4% | 0.03% | -43.4% |
Q1 2021 | $2,480,000 | +335.1% | 221,700 | +342.4% | 0.05% | +307.7% |
Q4 2020 | $570,000 | -34.9% | 50,113 | -48.6% | 0.01% | -35.0% |
Q3 2020 | $876,000 | -53.4% | 97,500 | -46.5% | 0.02% | -68.3% |
Q2 2020 | $1,880,000 | +314.1% | 182,300 | +305.1% | 0.06% | +142.3% |
Q1 2020 | $454,000 | -78.5% | 45,000 | -71.7% | 0.03% | -63.4% |
Q4 2019 | $2,116,000 | +134.9% | 159,000 | +51.4% | 0.07% | +51.1% |
Q3 2019 | $901,000 | -45.3% | 105,000 | -30.2% | 0.05% | -43.4% |
Q2 2019 | $1,646,000 | -28.2% | 150,400 | -25.7% | 0.08% | -34.1% |
Q1 2019 | $2,291,000 | +10.6% | 202,400 | +1.2% | 0.13% | -23.6% |
Q4 2018 | $2,072,000 | – | 200,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |